Alto Neuroscience, Stock Forecast - Accumulation Distribution
| ANRO Stock | 4.28 0.05 1.15% |
Alto Stock Forecast is based on your current time horizon. Although Alto Neuroscience,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Alto Neuroscience,'s systematic risk associated with finding meaningful patterns of Alto Neuroscience, fundamentals over time.
Alto |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 5889.3 | 0.0489 |
| Check Alto Neuroscience, Volatility | Backtest Alto Neuroscience, | Information Ratio |
Alto Neuroscience, Trading Date Momentum
| On November 29 2024 Alto Neuroscience, was traded for 4.28 at the closing time. The top price for the day was 4.50 and the lowest listed price was 4.28 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.87% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Alto Neuroscience, to competition |
Other Forecasting Options for Alto Neuroscience,
For every potential investor in Alto, whether a beginner or expert, Alto Neuroscience,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alto Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alto. Basic forecasting techniques help filter out the noise by identifying Alto Neuroscience,'s price trends.Alto Neuroscience, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alto Neuroscience, stock to make a market-neutral strategy. Peer analysis of Alto Neuroscience, could also be used in its relative valuation, which is a method of valuing Alto Neuroscience, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Alto Neuroscience, Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Alto Neuroscience,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Alto Neuroscience,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alto Neuroscience, Market Strength Events
Market strength indicators help investors to evaluate how Alto Neuroscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alto Neuroscience, shares will generate the highest return on investment. By undertsting and applying Alto Neuroscience, stock market strength indicators, traders can identify Alto Neuroscience, entry and exit signals to maximize returns.
Alto Neuroscience, Risk Indicators
The analysis of Alto Neuroscience,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alto Neuroscience,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alto stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.69 | |||
| Standard Deviation | 9.84 | |||
| Variance | 96.92 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Alto Neuroscience,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will appreciate offsetting losses from the drop in the long position's value.Moving together with Alto Stock
| 0.78 | HLN | Haleon plc | PairCorr |
| 0.77 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.76 | PFE | Pfizer Inc Aggressive Push | PairCorr |
Moving against Alto Stock
| 0.68 | FNMFO | Federal National Mortgage Upward Rally | PairCorr |
| 0.64 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.61 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.48 | ITCL | Banco Ita Chile | PairCorr |
| 0.47 | KB | KB Financial Group | PairCorr |
The ability to find closely correlated positions to Alto Neuroscience, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience, to buy it.
The correlation of Alto Neuroscience, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Alto Neuroscience, to cross-verify your projections. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.